Figure 2(a) shows the average results of multiple cloning experiments comparing the cloning efficiencies (C.E.s) of normal and CML total CD34+ cells and the G0 and G1/S/G2/M subsets. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.